Maisto papildas Aliness Sodium Butyrate + Calcium DUO 700mg 100 kapsulių

Trumpai apie prekę

Prekė: Maisto papildas Aliness Sodium Butyrate + Calcium DUO 700mg 100 kapsulių. Kategorija: Vitaminų ir mineralų papildai.

• Gamintojas: Aliness
• Modelis: Zdrowa okrężnica ENERGIA Przewód Pokarmowy
• Svoris: 120 g

Dietary supplement

100 capsules (gastro-resistant microcapsules)

Next generation prolonged and controlled release butter

Patented microPEARLS™ technology for controlled release in the digestive tract.

Sodium butyrate + Calcium buttermilk - double action

225 mg of butyric acid

Enteral release

100 capsules

Ingredients 1 capsule 2 capsules (daily dose)

Sodium butyrate 350 mg 700 mg

of which butyric acid 100 mg 200 mg

Calcium butter 350 mg 700 mg

of which butyric acid 125 mg 250 mg

Ingredients: sodium butyric acid in the form of gastro-resistant microcapsules, microcapsule shell (vegetable stearic acid), calcium salt of butyric acid, matrix: certified completely hydrogenated palm oil without trans isomers, rapeseed lecithin, thickener: maize starch, capsule shell: binder: hydroxypropylcellulose

Recommended daily intake: 1 capsule twice a day (morning and evening). It is recommended to use the preparation for at least 3 months.

Do not exceed the recommended portion for consumption during the day. Dietary supplements cannot be used as a substitute (replacement) for a varied diet. To maintain proper health, you should follow a varied diet and lead a healthy lifestyle.

Storage: Store at room temperature out of reach of small children. Protect from light and moisture.

THE ROLE OF BUTYRIC ACID IN THE BODY:

-Main energy source for healthy colon cells

-Supports the structure, function, and integrity of the intestinal barrier

-Supports and regulates gene expression at the cellular and DNA levels

-Supports the digestive tract environment

Why Butter DUO Aliness ?

-It is a microencapsulated source of butyric acid produced using

author's method of spraying process on the matrix layer

-Patented MicroPEARLS™ technology allows for permanent and controlled release of butyric acid throughout the digestive tract

-Calcium butter does not require enzymatic release (lipase)

-Calcium butter contains about 7% calcium (about 25 mg of calcium ions in 1 capsule)

-Low-smelling butyric acid matrix pellets

-Microcapsule sodium butyrate

-Sodium butyrate without hardened palm oil

The only calcium butyrate on the market clinically tested in healthy individuals, including mainly women, which has been proven to have benefits for the digestive tract (subjective data) and metabolic indicators (objective data).

The results confirm previous scientific data indicating that butyrate has a beneficial effect on both the digestive tract and parenteral aspects. *

Unique on the market dietary supplement BUTTER DUO allowing you to enrich your diet with butyric acid thanks to the combination of calcium butter and sodium butyrate.

Calcium butter is less soluble in aqueous solutions than sodium butyrate which, combined with the patented encapsulation and suspension technology in a special matrix, makes its release longer in the intestinal passage and more controlled (reaches the right place in the digestive system) and is released gradually throughout the intestinal passage.

In contrast, the use of microcapsule technology in sodium butyrate protects against the complete release of butyric acid in the upper gastrointestinal tract and allows it to be delivered to the small and large intestines. The microcapsule passes with the food content into the small intestine and further into the large, where further amounts of sodium butyrate are released. The composition of the microcapsule is selected so that the process of releasing sodium butyrate takes place along the entire length of the small and large intestine.

Butyric acid is one of the short chain fatty acids (SCFA) physiologically produced in the intestines in the process of fiber fermentation, research on the occurrence and role of SCFA in the digestive system has been ongoing for over 40 years.

The largest (~ 80%) share in SCFA present in the human digestive system are 3 types of acids: acetic, propionic and butyric occurring in fairly constant proportions: 60:25:15.

The proportion of butyric acid is the smallest, but it is the main source of energy for colonocytes (colon epithelial cells) and stimulates their growth and differentiation. Acetate and propionate are metabolized after the use of butter.

The unique patented microPEARLS™ production technology provides the effect of prolonged and controlled release of butyric acid in the digestive tract. Compared to unencapsulated calcium butyrate, Butishield is much more resistant to decomposition at a lower pH of the initial sections of the digestive system and thus most of it reaches the large intestine where it is most needed.

In addition to the “targeted” release site in the gastrointestinal tract, ButiShield™ Calcium Butter production technology allows for more acceptable organoleptic characteristics (mainly odor) than typical sodium butyrate.

Sodium butyrate in the product Butter DUO by Aliness is the only product on the market for the coating process of the active substance uses stearic acid, not hardened palm oil. Stearic acid is a naturally occurring fatty acid, which due to its specificity can no longer be subjected to hydrogenation / hardening reaction, because it is saturated acid.

The stearic acid of the shell is of plant origin and is completely natural.

*First clinical trial performed on ButiShield™ calcium butyrate.

Clinical Study: Effects of calcium butyrate on gut health outcomes in healthy adults (open-label study).

Researcher: Biofortis Research (Addison, IL)

Objective: To investigate the effect of a dietary supplement containing microencapsulated calcium butyrate (ButiShield) on gastrointestinal health parameters in healthy adults.

Methodology: Clinical trial in uncontrolled subjects

Duration: 42 days

Specifications